Controlled release application of multilamellar vesicles: a novel drug delivery approach

被引:22
作者
Agnihotri, Sunil A. [1 ]
Soppimath, Kumaresh S. [1 ]
Betageri, Guru V. [1 ]
机构
[1] Western Univ Hlth Sci, Dept Pharmaceut Sci, Pomona, CA 91766 USA
关键词
Multiparticulate systems; metoclopramide; proliposomes; multilamellar vesicles; controlled release; drug delivery; ORAL ABSORPTION; LIPOSOMES; ENCAPSULATION; STABILITY; FORMULATION; CHITOSAN;
D O I
10.3109/10717540903509027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A novel multilamellar vesicular delivery system was developed for the controlled release application. Multilamellar vesicles were prepared by thin film hydration and converted into proliposomes by freeze-drying. A model drug metoclopramide, a highly hydrophilic drug, was successfully encapsulated into proliposomes. The proliposomes produced were non-sticky, free-flowing powders. The proliposomes were formulated into a unit dosage form by combining with various excipients. The effect of different compositions such as type and concentration of phospholipid or hydrophilic polymer was investigared to optimize the formulation. The formation of multilamellar vesicles was confirmed by observing the process of hydration of proliposomes under an optical microscope. The spherical shape of vesicles was confirmed by transmission electron microscopy (TEM) and mean particle sizes were in the range of 1.3-2.5 mu m, as measured by dynamic light scattering technique. Differential scanning calorimetry (DSC) study of formulations was conducted to understand the crystalline nature of drug in the vesicles. The results indicated a molecular level dispersion of drug into proliposomes with encapsulation efficiency up to 43%. Critical formulation parameters were identified to obtain a near zero order in vitro release pattern. Proliposomal formulations produced were suitable as multiparticulate drug delivery systems for the controlled release of a highly hydrophilic molecule.
引用
收藏
页码:92 / 101
页数:10
相关论文
共 30 条
[1]   Formulation and evaluation of novel tableted chitosan microparticles for the controlled release of clozapine [J].
Agnihotri, SA ;
Aminabhavi, TM .
JOURNAL OF MICROENCAPSULATION, 2004, 21 (07) :709-718
[2]  
[Anonymous], MARTINDALES EXTRA PH
[3]  
Baker R.W., 1974, Controlled Release of Biologically active Agents, P15
[4]   LIPOSOMAL ENCAPSULATION AND STABILITY OF DIDEOXYINOSINE TRIPHOSPHATE [J].
BETAGERI, GV .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (05) :531-539
[5]   DRUG ENCAPSULATION AND RELEASE FROM MULTILAMELLAR AND UNILAMELLAR LIPOSOMES [J].
BETAGERI, GV ;
PARSONS, DL .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 81 (2-3) :235-241
[6]  
BETAGERI GV, 1999, MICROSPHERES MICROCA, V1, P490
[7]  
Betageri GV, 2005, US Patent, Patent No. [6,849,269, 6849269]
[8]  
BETAGERI GV, 2004, Patent No. 6759058
[9]   Tableting of coated pellets [J].
Bodmeier, R .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (01) :1-8
[10]   Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation [J].
Brocks, DR ;
Betageri, GV .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (08) :1049-1053